Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
13.00
-1.30 (-9.09%)
At close: Mar 3, 2026
-21.69%
Market Cap 1.35B
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 103.81M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend 0.11 (0.77%)
Ex-Dividend Date Dec 17, 2025
Volume 1,285,309
Average Volume 644,311
Open 14.10
Previous Close 14.30
Day's Range 12.90 - 14.20
52-Week Range 11.10 - 18.50
Beta 0.22
RSI 33.34
Earnings Date Apr 28, 2026

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 313
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SILCOPHL
Full Company Profile

Financial Performance

In fiscal year 2024, Silco Pharmaceuticals's revenue was 410.10 million, a decrease of -11.75% compared to the previous year's 464.70 million. Earnings were 45.88 million, a decrease of -33.72%.

Financial Statements

News

There is no news available yet.